These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9886299)

  • 1. Bone disease in multiple myeloma.
    Croucher PI; Apperley JF
    Br J Haematol; 1998 Dec; 103(4):902-10. PubMed ID: 9886299
    [No Abstract]   [Full Text] [Related]  

  • 2. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma.
    Bataille R; Chappard D; Klein B
    Int J Clin Lab Res; 1992; 21(4):283-7. PubMed ID: 1591381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myelomatous bone involvement in the man].
    Bataille R; Alexandre C; Chappard D
    Rev Rhum Ed Fr; 1993 Apr; 60(4):261-5. PubMed ID: 8167621
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of the microenvironment in multiple myeloma bone disease.
    Huston A; Roodman GD
    Future Oncol; 2006 Jun; 2(3):371-8. PubMed ID: 16787117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and treatment of multiple myeloma bone disease].
    Ma J
    Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):292-4. PubMed ID: 23668196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complications and their management in multiple myeloma patients: bone disease, renal impairment and peripheral neuropathy].
    Sakai A
    Rinsho Ketsueki; 2012 Oct; 53(10):1689-98. PubMed ID: 23037741
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.
    Anderson K; Ismaila N; Kyle RA
    J Oncol Pract; 2018 Apr; 14(4):266-269. PubMed ID: 29517956
    [No Abstract]   [Full Text] [Related]  

  • 8. Adoptive B-cell transfer mouse model of human myeloma.
    Tompkins VS; Rosean TR; Holman CJ; DeHoedt C; Olivier AK; Duncan KM; Jing X; Foor SD; Acevedo MR; Walsh SA; Tricot G; Zhan F; Janz S
    Leukemia; 2016 Apr; 30(4):962-6. PubMed ID: 26202932
    [No Abstract]   [Full Text] [Related]  

  • 9. [Integrated supportive therapy for multiple myeloma-bone disease treatment, myeloma kidney treatment, cryotherapy, nutrition support team].
    Miwa A
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():603-27. PubMed ID: 23134022
    [No Abstract]   [Full Text] [Related]  

  • 10. Biology and treatment of myeloma related bone disease.
    Terpos E; Christoulas D; Gavriatopoulou M
    Metabolism; 2018 Mar; 80():80-90. PubMed ID: 29175022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloma bone disease.
    Berenson JR
    Best Pract Res Clin Haematol; 2005; 18(4):653-72. PubMed ID: 16026743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple myeloma of the bone].
    Facon T
    Rev Prat; 2002 Jan; 52(1):63-70. PubMed ID: 11852769
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic role of bisphosphonate and radiation combination in the management of myeloma bone disease.
    Ural AU; Avcu F
    Clin Cancer Res; 2007 Jun; 13(11):3432. PubMed ID: 17545554
    [No Abstract]   [Full Text] [Related]  

  • 14. [Multiple Myeloma: from Diagnosis to the Up-to-date Treatment. Topics: III. Bone Disease in Multiple Myeloma].
    Udaka K; Ozaki S
    Nihon Naika Gakkai Zasshi; 2016 Jul; 105(7):1216-23. PubMed ID: 30168965
    [No Abstract]   [Full Text] [Related]  

  • 15. [Growth factors in multiple myeloma].
    Klein B; Bataille R
    Presse Med; 1990 Dec; 19(43):1972-3. PubMed ID: 2149597
    [No Abstract]   [Full Text] [Related]  

  • 16. Signalling and survival pathways in multiple myeloma.
    Bommert K; Bargou RC; Stühmer T
    Eur J Cancer; 2006 Jul; 42(11):1574-80. PubMed ID: 16797970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supportive therapy in multiple myeloma.
    Ludwig H; Zojer N
    Recent Results Cancer Res; 2011; 183():307-33. PubMed ID: 21509692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the pathophysiology and management of bone disease in multiple myeloma.
    Terpos E; Politou M; Rahemtulla A
    Br J Haematol; 2003 Dec; 123(5):758-69. PubMed ID: 14632767
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis and management of myeloma bone disease.
    Christoulas D; Terpos E; Dimopoulos MA
    Expert Rev Hematol; 2009 Aug; 2(4):385-98. PubMed ID: 21082944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma bone disease: pathogenesis, current treatments and future targets.
    Walker RE; Lawson MA; Buckle CH; Snowden JA; Chantry AD
    Br Med Bull; 2014 Sep; 111(1):117-38. PubMed ID: 25190762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.